Surgery Partners, Inc. cash flow to debt ratio of 6.82% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Surgery Partners, Inc.'s free cash flow has decreased 6.72% from $209.70M last year to $195.60M, signaling decreasing performance

Surgery Partners, Inc.'s debt to equity ratio is 0.22, which means that the company's assets are healthy financed, signaling financial stability.

Surgery Partners, Inc.'s debt has decreased relative to shareholder equity from 2.07 last year to 0.22 today, signaling strengthened financials

Surgery Partners, Inc. has a net debt to EBITDA ratio of 6.69x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Surgery Partners, Inc.'s interest coverage ratio is 0.60, which means that the company struggles to meet interest obligations, signaling financial risk.

Surgery Partners, Inc.'s profit margin has increased (-51.24%) in the last year from -5.40% to -2.63%, signaling increasing performance

Surgery Partners, Inc.'s short-term assets of $1.15B exceed its short-term liabilities of $615.50M

Surgery Partners, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Surgery Partners, Inc.'s return on equity of -5.21%, is lower than 15.00%, indicating bad performance

Surgery Partners, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Surgery Partners, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Surgery Partners, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Surgery Partners, Inc. has a free cash flow yield of 9.38%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Surgery Partners, Inc.'s yearly earnings has increased -53.66% since last year from $-168.10M to $-77.90M, signaling increasing performance

Surgery Partners, Inc.'s yearly revenue has increased 6.24% since last year from $3.11B to $3.31B, signaling increasing performance

ROIC 4.23% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Surgery Partners, Inc.'s 3-year revenue CAGR of 9.22% is positive, indicating growing revenue over the past 3 years

Surgery Partners, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Surgery Partners, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Surgery Partners, Inc. has insufficient data to evaluate this check.

Surgery Partners, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Surgery Partners, Inc. is overvalued relative to its fair value price of 1.35 based on EBITDA multiple model

Surgery Partners, Inc. has an EV/EBITDA ratio of 10.38x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Surgery Partners, Inc. is undervalued relative to its fair value price of 72.67 based on Earnings Fair Value model

Surgery Partners, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Surgery Partners, Inc. has a price-to-book ratio of 0.59x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Surgery Partners, Inc. has a price-to-sales ratio of 0.61x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue